Deep vein thrombosis and other clots
A deep vein thrombosis (DVT) is a clot in one of the deep veins, almost always in a leg, sometimes in an arm. It matters for two reasons. A piece of it can break off and travel to the lung, which is a pulmonary embolism, and that is the reason it is treated urgently. And a clot left in a leg vein damages the vein's valves, so that years later the leg swells, aches and can ulcerate. Both are preventable, and the prevention of the first is the same tablet on the same day.
1. Recognising it
Swelling of one calf or one whole leg, warmth, tenderness along the inside of the calf or thigh, reddish or bluish skin, and surface veins that stand out. Usually one side only, usually over hours to a day or two. About half of DVTs cause no symptoms at all and are found only after the piece that broke off reached the lung. The things that mimic it — a torn calf muscle, cellulitis, a ruptured Baker's cyst — are covered in the recognising-it chapter, along with the arm, the skin and the rare sites.
2. What should happen
A score
The clinician rates how likely a DVT is (the Wells score). Two points or more is "likely".
Likely: a leg ultrasound within four hours
If it cannot be done in four hours, a D-dimer blood test and an anticoagulant now, and the scan within 24 hours.
Unlikely: a D-dimer within four hours
Normal, and it is not a DVT. Raised, and the ultrasound follows, with an anticoagulant in the meantime if the scan will take more than four hours.
The repeat scan
A normal first scan with a raised D-dimer needs a second ultrasound six to eight days later, because a calf clot can grow into the range the scan sees.
Home on tablets
Apixaban or rivaroxaban, started the same day, for at least three months. Most people never need a hospital bed.
The leg pathway chapter has each step with its NICE recommendation number; the printable checklist puts them on one sheet.
3. Treatment, and the leg afterwards
The anticoagulant does not dissolve the clot; it stops it growing and stops new ones while the body clears it over weeks to months. For a small number of people with a large clot high in the leg, a catheter can be used to break it up; for the very few who cannot take anticoagulants, a filter is placed in the main vein of the abdomen. Between a fifth and a half of people develop the post-thrombotic leg over the next two years. Compression stockings do not prevent it, whatever you were told; walking, weight and treating the clot properly are what count. The treatment chapter has the numbers.
Everything else — which tablet, the three-month review where continuing or stopping is decided, the search for a cause, cancer and genetic testing, travel, contraception and pregnancy — is the same for a DVT as for a pulmonary embolism, and it is written once, in the after-hospital and lifestyle chapters of the PE topic.
4. Clots in unusual places
An arm clot, usually around a drip line or in a young athlete who has been overusing the arm. A clot in the veins of the abdomen, which presents as pain and needs a search for its cause. A clot in the veins draining the brain, which presents as a headache that does not behave like a migraine and is treated with an anticoagulant even when it has caused bleeding. And a clot in a surface vein — thrombophlebitis — which is harmless when it is small and far from the deep veins and is a DVT in waiting when it is not. The unusual-sites chapter covers each.
5. Prevention
Most clots that happen in hospital are preventable, and NICE requires every patient admitted to be assessed for the risk on the day they arrive. The prevention is heparin injections, inflatable leg sleeves, or both, continued after some operations for a month. The prevention chapter is written so you can check it happened, and covers travel and hormones.
6. Where UK and US guidance differ
Less than for the other two clot topics. The diagnosis pathway, the tablets and the duration are the same. The US guidelines are more willing to anticoagulate a clot confined to the calf and to use catheter treatment for large thigh clots; the UK position on both is narrower, and the chapters say where.
Pulmonary embolism: a clot in the lung
A pulmonary embolism (PE) is a blood clot that has lodged in one of the arteries of the lung. It almost always starts somewhere else — usually a deep vein in the leg or pelvis — breaks free, travels through the heart, and stops where the lung's arteries narrow. Small ones are survivable and common. Large ones can stop the heart within minutes. The difference between the two is mostly size and luck, which is why the treatment for both is urgent.
1. What it feels like
The textbook picture is breathlessness that came on over minutes, a sharp pain in the chest or side that is worse when you breathe in, and a fast heartbeat. Some people cough up blood. Some faint. Around half have a leg that is swollen, warm or aching — the deep vein thrombosis (DVT) the clot came from.
The dangerous versions are the quiet ones. Breathlessness on its own, that a person puts down to being unfit. A fast pulse and nothing else. A collapse with no warning. Unusual anxiety with a feeling of not getting enough air. These get attributed to a chest infection, a panic attack or a pulled muscle, and the clot is found days later or not at all. The recognising-it chapter goes through each of them.
Who it happens to. Anyone, but the risk climbs sharply after surgery, a hospital stay, a broken leg, a long period in bed or a chair, cancer, pregnancy and the weeks after birth, the combined pill or HRT, and a previous clot. Around one in three has no obvious trigger at all, and that group needs the most careful follow-up.
2. What should happen in hospital
A structured assessment, not a guess
The clinician scores how likely a PE is (the Wells score). A "likely" score goes straight to a scan. An "unlikely" score gets a blood test called D-dimer first; if it is normal, PE is effectively ruled out and no scan is needed.
The scan, within four hours if possible
Usually a CT pulmonary angiogram (CTPA): a CT scan of the chest with dye in the blood, which shows the clot directly. A lung ventilation-perfusion scan is the alternative when contrast dye or radiation is a problem. If the scan cannot happen within four hours, an anticoagulant should be started while you wait.
A blood panel, an ECG and a chest X-ray
Full blood count, kidney and liver function, clotting tests, and usually troponin and BNP, two blood markers of strain on the heart. These decide how sick you are, not whether you have a clot.
A decision about how serious it is
Most PEs are "low risk": blood pressure normal, heart coping. Many of those people go home the same day on tablets. A minority are "high risk", with a struggling heart and falling blood pressure, and get clot-busting drugs. In between is the group where 2026 changed the argument — see the treatment chapter.
An anticoagulant, usually a tablet
In the UK the first choices are apixaban or rivaroxaban, started on the day of diagnosis and continued for at least three months. They do not dissolve the clot; they stop it growing and stop new ones forming while the body clears it.
The hospital checklist chapter lists every test with the time limit NICE sets, and the printable version fits on one sheet.
3. The months after
At three months (three to six with cancer) there should be a review, and it is a real decision: stop the anticoagulant, or continue it. If the clot had a clear one-off cause that has gone — an operation, a leg in plaster — stopping is usually right. If it had no cause, most people are advised to continue, often for years, because the chance of another is high and the tablets are safer than they used to be. That decision should be made with you, and it should be reviewed every year.
The same review is when a cause should be looked for. What that means in practice is narrower than people expect: a proper examination and the routine bloods, not a scan of the whole body. Genetic clotting tests are only worth doing when the answer would change the decision to stop treatment. The after-hospital chapter explains why.
One thing to raise yourself. Around one person in three is still short of breath or tired months after a PE. Most of that is deconditioning and recovers. A small number — about 3 in 100 — develop a chronic form where old clot scars the lung's arteries and raises the pressure in them. It is treatable, and the test for it is a heart ultrasound. If you are still breathless at three to six months, ask for one.
4. Where UK and US guidance differ
Both agree on the tablets, the scan and the three-month review. They part company in the middle of the severity range. In March 2026 the US cardiology societies published a guideline that opened catheter treatment — threading a tube into the lung artery to dissolve or remove the clot — to patients whose blood pressure is holding but whose heart is under strain, and two trials that year showed it cut early deterioration. NICE's guidance in the UK still says no clot-busting unless blood pressure has collapsed. That is not carelessness on NICE's part: the trials are new and neither showed a survival benefit. But if you or a relative are in that middle group, it is a reasonable thing to ask about, and the treatment chapter gives you the numbers to ask with.